A phase III trial of docetaxel vs docetaxel and radium-223 in patients with #mCRPC #DORA. Presentation by @morr316 @sloan_kettering. #ASCO21 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://bit.ly/34SO3UA @ASCO @DrScottTagawa @Tiahigano
Decreased fracture rate by mandating bone protecting agents in the EORTC 1333/PEACEIII trial combining Radium-223 with enzalutamide vs enzalutamide alone: an updated safety analysis. @Silke_Gillessen. #ASCO21 written coverage by @aloktewar > https://bit.ly/3H18pwC @ASCO
Concomitant infections in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study - @KEnriquez_ et al. #ASCO21 Abstract 6561 https://meetings.asco.org/abstracts-presentations/198968 #NCT04354701 #CCC19 #COVDI19nCancer n = 6732 patients
🚨@oncoalert: Cancer sinks your credit.
Phenomenal work from Dr @ShankaranVeena et al in @JCO_ASCO: Patients with #cancer were at⬆️risk of 1) experiencing adverse financial events and 2) having past-due credit card payments. #financialToxicity #ASCO21 https://ascopubs.org/doi/10.1200/JCO.21.01636?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Thierry André, MD, on Pembrolizumab vs Chemotherapy in MSI-High Colorectal Cancer https://ascopost.com/videos/2021-asco-annual-meeting/thierry-andre-on-pembrolizumab-vs-chemotherapy-in-msi-high-colorectal-cancer/ #ASCO21 #crcsm #oncology #cancer #immunotherapy @HopSaintAntoine
